SCHEMBL14447461

SCHEMBL14447461

CCCCCn1c2ccccc2n2c(=O)c(C)c(C)nc12

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 5/20 0.46
SMN1; SMN2 Q16637 1/20 0.46
PLK1 P53350 1/20 0.46
APOBEC3G Q9HC16 1/20 0.46
TLR8 Q9NR97 3/20 0.44
ADORA2A P29274 2/20 0.44
CYP1A2 P05177 1/20 0.44
GLA P06280 1/20 0.44
CYP2D6 P10635 1/20 0.44
CYP2C9 P11712 1/20 0.44
CYP2C19 P33261 1/20 0.44
NPSR1 Q6W5P4 1/20 0.44
ADORA1 P30542 1/20 0.43
PGR P06401 1/20 0.43
RORA P35398 1/20 0.43
RORC P51449 1/20 0.43
RORB Q92753 1/20 0.43
KDM4E B2RXH2 4/20 0.42
HPGD P15428 3/20 0.42
LMNA P02545 2/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13317079 0.85 POLB (0.48) ALDH1A1PLK1ADORA1KDM4EHPGD
SCHEMBL13317113 0.84 ADORA1 (0.46) ALDH1A1ADORA2AADORA1KDM4EHPGD
SCHEMBL13317101 0.84 ADORA1 (0.46) ALDH1A1ADORA1KDM4ELMNATP53
SCHEMBL13317087 0.82 KDM4E (0.47) ALDH1A1SMN1; SMN2PLK1APOBEC3GADORA1
SCHEMBL13317100 0.82 TOP2A (0.47) ALDH1A1CYP1A2ADORA1KDM4EHPGD
SCHEMBL13317103 0.81 POLB (0.45) ALDH1A1SMN1; SMN2PLK1CYP1A2CYP2C19
SCHEMBL11825502 0.81 SMN1; SMN2 (0.51) ALDH1A1SMN1; SMN2PLK1APOBEC3GTLR8
SCHEMBL11827984 0.80 TDP1 (0.53) ALDH1A1SMN1; SMN2PLK1APOBEC3GTLR8
SCHEMBL11821502 0.80 TDP1 (0.53) ALDH1A1SMN1; SMN2PLK1APOBEC3GTLR8
SCHEMBL13317102 0.80 NPSR1 (0.44) ALDH1A1SMN1; SMN2NPSR1ADORA1KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1451196-B1 The use of substituted tetracyclic imidazole derivatives as anti-histaminics JANSSEN PHARMACEUTICA NV (BE) 2007-08-15 EP disclosed